Hazard Information | Back Directory | [Description]
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. |
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
www.bocsci.com |
|